Retinal Nerve Fibre Layer Loss in Patients with Pituitary Adenoma
Abstract
Introduction. Pituitary adenoma (PA) is a non-malignant tumour, which grows from the hypophysis' frontal lobe adenohypophysis cells [1]. Ezzat et al. reported the estimated prevalence rates of PA to be 14.4% to 22.5% in pooled autopsy and radiological series, respectively [2]. The pituitary gland is localized in a dural bag attached to the inferior aspect of the diaphragm of sella and surrounded by venous spaces that correspond laterally to the cavernous sinuses [3]. PA may grow large and extend into surrounding structures resulting in neurological complications including visual impairment [4-7]. Early diagnosis of these tumours is very important because long standing chiasmal compression indicates primary optic atrophy and a poor prognosis for visual recovery following surgical decompression [1]. The size of the adenoma corresponds with compromising effects on the optic chiasm, cranial nerves, and cavernous sinuses, but tumour size does not reflect its clinical importance [8]. Abnormalities in the retinal nerve fibre layer (RNFL) in long-standing lesions are also characteristic [9].
Optical coherence tomography (OCT) can quantify RNFL thickness to determine the loss. OCT provides cross-sectional images of tissue structure on the micron scale by measuring the echo delay time of back-scattered infrared light using an interferometer and a low-coherence light source [10]. In patients with chiasmal lesions, the crossed nerve fibres are lost with preservation of the uncrossed nerve fibres, which originate in the temporal hemiretinal, and penetrate the optic nerve through the superior and inferior arcuate fibre bundles. Thus, RNFL loss occurs predominantly on the nasal and temporal side of the optic disc [11].
The aim of our study was to estimate RNFL thickness by using OCT in patients with micro and macro PA.
Methods. Permission to undertake the study was obtained from the Ethics Committee for Biomedical research. The study was carried out at the Department of Ophthalmology, Department of Neurosurgery, Lithuanian University of Health Sciences.
Twenty four persons (48 eyes) with macroadenomas and 10 persons (20 eyes) with microadenomas were examined. Adenomas which were 10 mm or larger were defined as macroadenomas, and those less than 10 mm in diameter were defined as microadenomas. PA was confirmed by magnetic resonance imaging scans. All patients were evaluated by slit-lamp biomicroscopy to assess corneal, lenticular transparency, optic nerve diseases, macular degenerations or dystrophy.
RNFL thickness was analysed with spectral domain OCT (RS 3000 Advance Nidec Co., Japan) after pupil dilatation before surgical treatment. Fundus surface images were captured with the confocal laser scanning using a near-infrared light source with a wavelength of 785 nm. Cross-sectional images of the retina were captured with the optical interferometer using an infrared light source with a wavelength of 880 nm. OCT image capture mode – disc circle mode: the patient‘s fundus is scanned circularly around the optic disk in the order of „Temporal“, „Superior“, „Nasal“, and „Inferior“ to obtain OCT images.
Results. A total of 34 participants were enrolled in the study. Twenty four patients had pituitary macroadenomas, 10 patients had pituitary microadenomas.
RNFL thickness around the optic disk measured preoperatively was reduced significantly in all four quadrants and average value in microPA patients compared with the patients with macroPA (see Table 1).
Table 1. Changes of retinal nerve fiber layer (RNFL) thickness in patients with pituitary microadenomas and macroadenomas
RNFL thickness, μm
Microadenomas median (min;max) mean rank
Macroadenomas median (min;max) mean rank
P Value
Superior
128 (109;164) 45.35
115.5 (60;158) 29,98
0.003*
Temporal
78 (52;94) 50.50
50.50 (19;99) 27,83
<0.001*
Inferior
136 (112;169) 51.50
109 (44;156) 27,42
<0.001*
Nasal
93 (66;104) 49.92
63,5 (25;126) 28,07
<0.001*
Average
111 (94;122) 51,28
85,67 (39;119) 27,51
<0.001*
* Mann-Whitney U test
Discussion. In the present study, we demonstrate that preoperatively assessed RNFL thickness in all four quadrants and average values were significantly smaller for macroadenomas patients compared with microadenomas patients. Numerous studies have found that OCT is able to identify the characteristic pattern of RNFL loss for patients with PA [11, 12].
Chiasmal tumors affecting the crossed nerve fibres and causing bitemporal hemianopia generally present changes in the nasal and temporal sides of the optic disc and this pattern identified as band atrophy (BA) [11-13]. The measurement of RNFL of eyes with BA represents an important model in the evaluation of the ability of OCT to quantify RNFL loss in the nasal and temporal areas of the optic disc [14-15]. Our study also showed more pronounced RNFL loss in the mentioned quadrants for patients with macro and microadenomas.
Our study shows that the RNFL was also reduced in the superior and inferior segments of the optic disc patients with PA. This is also in agreement with the study of Midelberg et al. They found that the loss of nerve fibres in eyes with BA the superior and inferior areas of the optic disc lost approximately 50% of their fibres, as ganglion cell axons originating from the nasal retina also penetrate in the superior and inferior portions of the disc [16].
Conclusions. OCT can provide useful information in the diagnosis of band atrophy from chiasmal lesions such as micro and macroadenomas.
Financial support. Lithuanian Science Council (grant no. MIP-008/2014).
References
1. Nistor R. Pituitary tumours. NeuroReview. 1996; 57: 264
2. Ezzat, S., Asa, S. L., Couldwell, W. T., Barr, C. E., Dodge, W. E., Vance, M. L. and McCutcheon, I. E.. The prevalence of pituitary adenomas. Cancer. 2004;101: 613–619.
3. Destrieux C, Kakou MK, Velut S, Lefrancq T, Jan M. Microanatomy of the hypophyseal bounderies. J Neurosurg 1998; 88:743-752
4. Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer. 2008;15:905–915
5. Kasputytė R, Slatkevičienė G, Liutkevičienė R, Glebauskienė B, Bernotas G, Tamašauskas A. Changes of visual functions in patients with pituitary adenoma. Medicina (Kaunas) 2013;49(3):132-7
6. Thomas R, Shenoy K, Seshadri MS, Muliyil J, Rao A, Paul P. Visual field defects in non-functioning pituitary adenomas. Indian J Ophthalmol 2002;50:127-30
7. Ferrante E, Ferraroni M, Castrignanò T, Menicatti L, Anagni M,Reimondo G, Del Monte P, Bernasconi D, Loli P, Faustini-Fustini M et al.. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumours. European Journal of Endocrinology 2006;155 823–829
8. Asa SL, Ezzat S: The pathogenesis of pituitary tumours. Nat Rev Cancer 2002, 2:836-49
9. Tanito M, Itai N, Goto T, Ohira A, Chihara E // Abnormalities of scanning laser polarimetry associated with pituitary adenoma. Am J Ophthalmol. 2003;135 (4). – P. 565 - 567
10. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178–81
11. Kanamori A, Nakamura M, Matsui N et al.. Optical coherence tomography detects characteristic retinal nerve fiber layer thickness corresponding to band atrophy of the optic disc. Ophthalmology 2004;111: 2278–2283
12. Unsold R, Hoyt WF. Band atrophy of the optic nerve. The histology of temporal hemianopsia. Arch Ophthalmol. 1980; 98:1637–1638
13. Monteiro MLR, Medeiros FA, Ostroscki MR. Quantitative analysis of axonal loss in band atrophy of the optic nerve using scanning laser polarimetry. Br J Ophthalmol. 2003;87(1):32-7
14. Monteiro MLR, Leal BC, Rosa AAM & Bronstein MD: Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve. Br J Ophthalmol 2004;88: 896–899
15. Monteiro MLR, Moura FC & Medeiros FA: Diagnostic ability of optical coherence tomography with a normative database to detect band atrophy of the optic nerve. Am J Ophthalmol 2007;143: 896–899
16. Midelberg FS, Yidegiligne HM. Axonal loss in band atrophy of the optic nerve in craniopharyngioma: a quantitative analysis. Can J Ophthalmol 1993;28:69–71
Refbacks
- There are currently no refbacks.
_______________________________________________________________________________________________________________________________________
BIOMEDICAL ENGINEERING CONFERENCE ORGANIZING COMMITEE,
BIOMEDICAL ENGINEERING INSTITUTE,
KAUNAS UNIVERSITY OF TECHNOLOGY.